Answers are grounded in this paper and cite their sources.
In vitro study reveals that DHHC-7 and DHHC-21 mediate steroid receptor membrane trafficking in cancer cells, highlighting new targets to block nongenomic signaling.
Classical estrogen, progesterone, and androgen receptors (ERs, PRs, and ARs) localize outside the nucleus at the plasma membrane of target cells. From the membrane, the receptors signal to activate kinase cascades that are essential for the modulation of transcription and nongenomic functions in many target cells. ER, PR, and AR trafficking to the membrane requires receptor palmitoylation by palmitoylacyltransferase (PAT) protein(s). However, the identity of the steroid receptor PAT(s) is unknown. We identified the DHHC-7 and -21 proteins as conserved PATs for the sex steroid receptors. From DHHC-7 and -21 knockdown studies, the PATs are required for endogenous ER, PR, and AR palmitoylation, membrane trafficking, and rapid signal transduction in cancer cells. Thus the DHHC-7 and -21 proteins are novel targets to selectively inhibit membrane sex steroid receptor localization and function.
No takes yet. Share an insight, caveat, or question.
Pedram et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: